Selective estrogen receptor modulators

Drug News and Perspectives

Volumn 8, Issue 9, 1995, Pages 531-539

  Kauffman, R F ^a   Bryant, H U ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA DIHYDROEQUILENIN; 3 [4 (1,2 DIPHENYL 1 BUTENYL)PHENYL]ACRYLIC ACID; ANTIESTROGEN; DROLOXIFENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; TAMOXIFEN; UNCLASSIFIED DRUG;

BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG RESEARCH; FEMALE; HEALTH; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR; UTERUS CANCER;

EID: 0029560877     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)